Leech Tishman Nelson Hardiman is proud to announce that Joshua G. Singer, and experienced healthcare attorney has joined the firm securing Nelson Hardiman’s position as the premier specialty healthcare and life sciences law firm in Los Angeles.
Joshua G. Singer joins Nelson Hardiman with deep experience advising and guiding the cannabis industry on regulatory and related business issues, as well as related healthcare and life science matters. Josh guides companies of all sizes in navigating the complex maze of state laws and municipal regulations, drawing as well on his experience in corporate transactional matters, licensing, and regulatory compliance. Josh has spent years of focus on the regulations that govern cannabis licensing and compliance in California and nationally. He has been personally responsible for securing hundreds of cannabises and other licenses for clients. He also counsels’ clients on managing the conflicts that exist between federal and state laws and municipal ordinances for cannabis manufacturers, cultivators, retailers, distributors, investors, and ancillary services around finance and tax issues. Josh is intimately familiar with the nuances of California law governing the multi-million-dollar legalized cannabis industry, particularly in the Greater Los Angeles area. Josh also brings valuable experience advising on corporate transactions and ensures regulatory compliance for other regulated substances, including psychedelics, and other innovative health products. His knowledge and experience make Josh a trusted advisor assisting a wide range of clients through the complex license process, adhering to local and state cannabis regulations, and providing legal counsel on business operations, corporate transactions, and tax laws. “Nelson Hardiman has always been a pioneer in emerging areas of healthcare and life sciences, and Josh’s regulatory and transactional legal skill and experience in the cannabis industry, made him a compelling addition to our team to continue to serve our client’s needs,” said healthcare chair and firm partner Harry J. Nelson.
“The addition of Josh is exciting on multiple levels,” commented Partner Mark S. Hardiman. “Healthcare and life sciences continue to be arenas of transition, innovation, and growth. Josh helps expand and deepen our roster of specialized talent. He is just the latest evidence that the firm continues to lead the way and that the pathway for healthcare and life sciences innovation runs through Nelson Hardiman.”